<--- Back to Details
First PageDocument Content
Eli Lilly and Company / Lysergic acid diethylamide / Novartis / Psychedelic research / Neurochemistry / Chemistry / Hallucinogen / Mescaline / Psychedelic therapy / Entheogens / Mind control / Research
Date: 2013-08-10 13:07:54
Eli Lilly and Company
Lysergic acid diethylamide
Novartis
Psychedelic research
Neurochemistry
Chemistry
Hallucinogen
Mescaline
Psychedelic therapy
Entheogens
Mind control
Research

Add to Reading List

Source URL: www.psychonautdocs.com

Download Document from Source Website

File Size: 854,06 KB

Share Document on Facebook

Similar Documents

Aquis Exchange Monthly Statistics May-2016 € 6,758,607,,245,455 Novartis AG

DocID: 1xVO3 - View Document

FTSE 100 Index / Stock market / Share trading

Aquis Exchange Monthly Statistics Dec-2015 € 4,614,167,,256,050 Novartis AG

DocID: 1xVKG - View Document

Aquis Exchange Monthly Statistics Apr-2016 € 7,708,388,,903,457 Novartis AG

DocID: 1xTdg - View Document

PDF Document

DocID: 1xJ9t - View Document

PDF Document

DocID: 1xzSc - View Document